https://www.selleckchem.com/products/ink128.html
Patent foramen ovale is a hemodynamically insignificant interatrial communication that may cause ischemic stroke. Percutaneous patent foramen ovale closure reduces the risk for recurrent ischemic stroke in patients with a history of cryptogenic ischemic stroke. This study evaluated the cost-effectiveness of patent foramen ovale closure against medical therapy in patients after their first cryptogenic ischemic stroke in Japan. The cost-effectiveness of patent foramen ovale closure compared with medical therapy was evaluated using the Mark
Like
Comment
Share
